Registered Kenya · PPB

ZYCET NASAL SPRAY

FLUTICANOSE FUROATE

H91/1942 27.5MCG GENERIC/BIOSIMILARS

What it does

Fluticasone is a medication often used to relieve symptoms of allergies and asthma. It helps reduce inflammation in the airways.

Commonly used for: allergic rhinitis (hay fever), asthma, chronic obstructive pulmonary disease (COPD)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H91/1942
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
FLUTICANOSE FUROATE
Dosage form
27.5MCG
Strength
-
Pack size
6G
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Biopharma
Applicant / LTR
BIOPHARMA LIMITED
Country of origin
LOCAL
Manufacturer location
Building No. 01, Road 01 Dhaka Housing Main Rd, Dhaka 1207, Bangladesh

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:13:05 · updated 2026-07-20 08:56:14

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Fluticasone is a medication often used to relieve symptoms of allergies and asthma. It helps reduce inflammation in the airways.

What it treats

  • allergic rhinitis (hay fever)
  • asthma
  • chronic obstructive pulmonary disease (COPD)

How it works

Fluticasone works by decreasing inflammation in the airways, making it easier to breathe and reducing allergy symptoms.

Who it's for

It is suitable for people suffering from asthma, allergies, or COPD.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: fluticanose

Fluticasone is a synthetic corticosteroid used primarily for its anti-inflammatory and immunosuppressive properties. It is commonly administered via inhalation, nasal spray, or topical formulations to manage conditions such as asthma, allergic rhinitis, and skin disorders. The drug acts by modulating the immune response and reducing inflammation in affected tissues, making it effective for managing chronic inflammatory conditions.

Indications

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Allergic Rhinitis
  • Eczema
  • Psoriasis

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on age and weight.

Adults: Refer to the BNF for specific dosing guidelines based on the formulation and condition being treated.

Mechanism of action

Fluticasone works by binding to the glucocorticoid receptor, leading to the regulation of gene expression that affects the synthesis of anti-inflammatory proteins and the inhibition of pro-inflammatory cytokines. This results in decreased inflammation, suppression of the immune response, and reduced mucous production, which is beneficial in treating asthma and allergic reactions.

Pharmacodynamics

Fluticasone exhibits potent anti-inflammatory effects and is significantly more effective than many other corticosteroids. It reduces the recruitment of eosinophils and other inflammatory cells to sites of inflammation, leading to lower levels of inflammatory mediators. Its clinical effect is observed in the reduction of airway hyperresponsiveness and improvement in lung function in asthmatic patients.

Pharmacokinetics

Fluticasone is well-absorbed when administered by inhalation or nasal route, but it undergoes extensive first-pass metabolism in the liver, which limits systemic exposure. The elimination half-life of fluticasone is approximately 8 hours. The drug is primarily excreted as metabolites in the feces and urine, with a low potential for systemic side effects due to its high local activity and low bioavailability.

Contra-indications

  • Hypersensitivity to fluticasone or any of its components
  • Active or untreated infections
  • Severe hypersensitivity reactions

Adverse effects

  • Nasal irritation or burning
  • Headache
  • Epistaxis (nosebleeds)
  • Pharyngitis
  • Cough
  • Systemic corticosteroid effects with prolonged use

Interactions

  • CYP3A4 inhibitors (e.g., ritonavir, ketoconazole) may increase fluticasone levels
  • Corticosteroids may interact with other medications that affect the immune system

Precautions

  • Use with caution in patients with active or quiescent tuberculosis infections
  • Monitor for signs of adrenal suppression or Cushing's syndrome with prolonged use
  • Patients with a history of glaucoma or cataracts should be monitored

Pregnancy

Fluticasone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Fluticasone is excreted in breast milk; caution is advised when administering to nursing women.

Storage

Store at room temperature, away from light and moisture. Do not freeze.

Formulations

  • Nasal spray
  • Inhalation aerosol
  • Topical cream

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.